Literature DB >> 26313559

Ex vivo normothermic perfusion for quality assessment of marginal donor kidney transplants.

S A Hosgood1,2, A D Barlow1,2, J P Hunter1, M L Nicholson1,2.   

Abstract

BACKGROUND: A significant proportion of kidneys procured for transplantation are discarded because of concerns about their suitability. In this study ex vivo normothermic perfusion (EVNP) was used as a quality assessment device before renal transplantation.
METHODS: Seventy-four human kidneys deemed unsuitable for transplantation following retrieval underwent 60 min of EVNP with an oxygenated red cell-based solution at 36°C. Receiver operating characteristic (ROC) curves were used to identify thresholds of renal blood flow and urine output. These thresholds and a grading of macroscopic appearance were incorporated into an EVNP assessment score (highest quality, 1; lowest, 5). This was applied to a series of 36 kidneys transplanted after EVNP.
RESULTS: In the discarded kidney series, 60 (81 per cent) scored 1-4 and 14 (19 per cent) scored 5. Although none of these kidneys was transplanted, those with a score from 1 to 4 were considered suitable for transplantation. In the 36 transplanted kidneys, the score ranged between 1 and 3 (score 1, 17; score 2, 11; score 3, 8). All of these kidneys were transplanted without any complications or primary non-function. The delayed graft function rate was 6 per cent (1 of 17) in kidneys scoring 1, 0 per cent (0 of 11) in those scoring 2 and 38 per cent (3 of 8) in those scoring 3 (P = 0·024). The mean(s.d.) estimated glomerular filtration rate at 12 months was 51(16), 63(15) and 38(21) ml in kidneys scoring 1, 2 and 3 respectively (P = 0·015).
CONCLUSION: EVNP combined with a simple scoring system is an innovative technology for pretransplant assessment of kidney quality and acceptability for transplantation. This study suggests that a high percentage of retrieved kidneys are being discarded unnecessarily.
© 2015 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26313559     DOI: 10.1002/bjs.9894

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  32 in total

1.  Synthetic hemoglobin-based oxygen carriers are an acceptable alternative for packed red blood cells in normothermic kidney perfusion.

Authors:  Mohamed M Aburawi; Fermin M Fontan; Negin Karimian; Corey Eymard; Stephanie Cronin; Casie Pendexter; Sonal Nagpal; Peony Banik; Sinan Ozer; Paria Mahboub; Francis L Delmonico; Heidi Yeh; Korkut Uygun; James F Markmann
Journal:  Am J Transplant       Date:  2019-04-26       Impact factor: 8.086

2.  CORM-401 Reduces Ischemia Reperfusion Injury in an Ex Vivo Renal Porcine Model of the Donation After Circulatory Death.

Authors:  Rabindra N Bhattacharjee; Mahms Richard-Mohamed; Qizhi Sun; Aaron Haig; Ghaleb Aboalsamh; Peter Barrett; Richard Mayer; Ibrahim Alhasan; Karen Pineda-Solis; Larry Jiang; Hajed Alharbi; Manujendra Saha; Eric Patterson; Alp Sener; Gediminas Cepinskas; Anthony M Jevnikar; Patrick P W Luke
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

3.  Impact of Red Blood Cells on Function and Metabolism of Porcine Deceased Donor Kidneys During Normothermic Machine Perfusion.

Authors:  Leonie H Venema; L Leonie van Leeuwen; Rene A Posma; Harry van Goor; Rutger J Ploeg; Patrick Hannaert; Thierry Hauet; Thomas Minor; Henri G D Leuvenink
Journal:  Transplantation       Date:  2022-08-27       Impact factor: 5.385

Review 4.  Machine perfusion in abdominal organ transplantation: Current use in the Netherlands.

Authors:  Elsaline Rijkse; Jan Nm IJzermans; Robert C Minnee
Journal:  World J Transplant       Date:  2020-01-18

5.  Phosphonate coating of commercial iron oxide nanoparticles for nanowarming cryopreserved samples.

Authors:  Jacqueline L Pasek-Allen; Randall K Wilharm; Zhe Gao; Valerie C Pierre; John C Bischof
Journal:  J Mater Chem B       Date:  2022-05-18       Impact factor: 7.571

6.  The use of ex-vivo normothermic perfusion for the resuscitation and assessment of human kidneys discarded because of inadequate in situ perfusion.

Authors:  Sarah A Hosgood; A D Barlow; J Dormer; M L Nicholson
Journal:  J Transl Med       Date:  2015-10-16       Impact factor: 5.531

7.  Protocol of a randomised controlled, open-label trial of ex vivo normothermic perfusion versus static cold storage in donation after circulatory death renal transplantation.

Authors:  Sarah A Hosgood; Kourosh Saeb-Parsy; Colin Wilson; Christopher Callaghan; Dave Collett; Michael L Nicholson
Journal:  BMJ Open       Date:  2017-01-23       Impact factor: 2.692

8.  Lowering Perfusate Temperature From 37°C to 32°C Diminishes Function in a Porcine Model of Ex Vivo Kidney Perfusion.

Authors:  Thomas D Adams; Meeta Patel; Sarah A Hosgood; Michael L Nicholson
Journal:  Transplant Direct       Date:  2017-02-23

9.  Successful Transplantation of Human Kidneys Deemed Untransplantable but Resuscitated by Ex Vivo Normothermic Machine Perfusion.

Authors:  S A Hosgood; K Saeb-Parsy; M O Hamed; M L Nicholson
Journal:  Am J Transplant       Date:  2016-07-13       Impact factor: 8.086

10.  Haemoadsorption reduces the inflammatory response and improves blood flow during ex vivo renal perfusion in an experimental model.

Authors:  Sarah A Hosgood; Tom Moore; Theresa Kleverlaan; Tom Adams; Michael L Nicholson
Journal:  J Transl Med       Date:  2017-10-25       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.